查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1418343

血糖儀市場報告：2030 年趨勢、預測與競爭分析

Glucometer Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

血糖儀的趨勢和預測

預計到 2030 年，全球血糖儀市場將達到 305 億美元，2024 年至 2030 年複合年成長率為 8.9%。該市場的主要促進因素是全球糖尿病盛行率不斷上升、醫療基礎設施成本不斷上升以及糖尿病管理知識的不斷增加。全球血糖儀市場的未來前景看好，機構銷售、醫院、診所、零售、醫院藥局、零售藥局和線上藥局市場都有機會。

血糖機市場洞察

Lucintel 預測，由於其易於使用且價格實惠，自我血糖監測系統在預測期內仍將是最大的細分市場。

由於醫院藥房為醫療保健專業人員提供便利，因此將繼續成為該市場的最大細分市場。

由於糖尿病盛行率高，北美在預測期內仍將是最大的地區。

常問問題

Q1.市場規模有多大？

A1. 到2030年，全球血糖儀市場預計將達到305億美元。

Q2.市場成長預測如何？

A2. 2024年至2030年，全球血糖儀市場預計將以8.9%的複合年成長率成長。

Q3.影響市場成長的主要促進因素有哪些？

A3. 該市場的主要驅動力是全球糖尿病盛行率不斷上升、醫療基礎設施成本不斷上升以及糖尿病管理知識不斷增加。

Q4.市場的主要細分市場是什麼？

A4. 血糖儀市場未來性廣闊，機構銷售、醫院、診所、零售、醫院藥局、零售藥局和網路藥局市場都有機會。

Q5.市場上主要企業有哪些？

A5. 主要血糖儀公司如下。

  • Thermo Fisher Scientific
  • Promega Corporation
  • Agilent Technologies
  • Bio-Rad Laboratories
  • QIAGEN
  • Merck
  • BD
  • Sanofi
  • Ascensia Diabetes Care Holdings
  • Abbott

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預測，由於自我血糖監測系統易於使用且價格實惠，因此在預測期內仍將是最大的細分市場。

Q7. 未來五年預計哪個地區將成為最大的市場？

A7. 由於糖尿病盛行率較高，北美在預測期內仍將是最大的地區。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球血糖機市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球血糖儀市場趨勢（2018-2023）與預測（2024-2030）
  • 全球血糖儀市場（按產品）
    • 連續血糖儀
    • 自我血糖測量系統
  • 按技術分類的全球血糖儀市場
    • 侵入性的
    • 非侵入性
  • 按類型分類的全球血糖儀市場
    • 穿戴式的
    • 不穿戴式
  • 按分銷通路分類的全球血糖儀市場
    • 設施銷售
    • 醫院
    • 診所
    • 零售銷售
    • 醫院藥房
    • 零售藥房
    • 網路藥房
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球血糖儀市場區域分佈
  • 北美血糖機市場
  • 歐洲血糖儀市場
  • 亞太血糖儀市場
  • 其他地區血糖儀市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球血糖儀市場成長機會（按產品）
    • 全球血糖儀市場技術成長機會
    • 按類型分類的全球血糖儀市場成長機會
    • 全球血糖儀市場成長機會（按分銷管道）
    • 全球血糖監測儀市場成長機會（按地區）
  • 全球血糖儀市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球血糖儀市場產能
    • 全球血糖儀市場的合併、收購與合資
    • 認證和許可

第7章主要企業概況

  • Thermo Fisher Scientific
  • Promega Corporation
  • Agilent Technologies
  • Bio-Rad Laboratories
  • QIAGEN
  • Merck
  • BD
  • Sanofi
  • Ascensia Diabetes Care Holdings
  • Abbott
簡介目錄

Glucometer Trends and Forecast

The future of the global glucometer market looks promising with opportunities in the institutional sales, hospitals, clinics, retail sales, hospital pharmacies, retail pharmacies, and online pharmacies markets. The global glucometer market is expected to reach an estimated $30.5 billion by 2030 with a CAGR of 8.9% from 2024 to 2030. The major drivers for this market are increasing prevalence of diabetes worldwide and rising costs for healthcare infrastructure and increased knowledge of diabetes management.

A more than 150-page report is developed to help in your business decisions.

Glucometer by Segment

The study includes a forecast for the global glucometer by product, technique, type, distribution channel, and region.

Glucometer Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Continuous Glucose Monitoring Devices
  • Self-Monitoring Blood Glucose Systems

Glucometer Market by Technique [Shipment Analysis by Value from 2018 to 2030]:

  • Invasive
  • Non-Invasive

Glucometer Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Wearable
  • Non-Wearable

Glucometer Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Institutional Sales
  • Hospitals
  • Clinics
  • Retail Sales
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Glucometer Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Glucometer Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies glucometer companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the glucometer companies profiled in this report include-

  • Thermo Fisher Scientific
  • Promega Corporation
  • Agilent Technologies
  • Bio-Rad Laboratories
  • QIAGEN
  • Merck
  • B.D.
  • Sanofi
  • Ascensia Diabetes Care Holdings
  • Abbott

Glucometer Market Insights

Lucintel forecasts that self-monitoring blood glucose systems will remain the largest segment over the forecast period due to easier to use and affordable.

Within this market, hospital pharmacies will remain the largest segment due to convenience to healthcare professionals.

North America will remain the largest region over the forecast period due to high prevalence of diabetes in the region.

Features of the Global Glucometer Market

Market Size Estimates: Glucometer market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Glucometer market size by various segments, such as by product, technique, type, distribution channel, and region in terms of value ($B).

Regional Analysis: Glucometer market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product, technique, type, distribution channel, and regions for the glucometer market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the glucometer market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the glucometer market size?

Answer: The global glucometer market is expected to reach an estimated $30.5 billion by 2030.

Q2. What is the growth forecast for glucometer market?

Answer: The global glucometer market is expected to grow with a CAGR of 8.9% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the glucometer market?

Answer: The major drivers for this market are increasing prevalence of diabetes worldwide and rising costs for healthcare infrastructure and increased knowledge of diabetes management.

Q4. What are the major segments for glucometer market?

Answer: The future of the glucometer market looks promising with opportunities in the institutional sales, hospitals, clinics, retail sales, hospital pharmacies, retail pharmacies, and online pharmacies markets.

Q5. Who are the key glucometer market companies?

Answer: Some of the key glucometer companies are as follows.

  • Thermo Fisher Scientific
  • Promega Corporation
  • Agilent Technologies
  • Bio-Rad Laboratories
  • QIAGEN
  • Merck
  • B.D.
  • Sanofi
  • Ascensia Diabetes Care Holdings
  • Abbott

Q6. Which glucometer market segment will be the largest in future?

Answer: Lucintel forecasts that self-monitoring blood glucose systems will remain the largest segment over the forecast period due to easier to use and affordable.

Q7. In glucometer market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to high prevalence of diabetes in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the glucometer market by product (continuous glucose monitoring devices and self-monitoring blood glucose systems), technique (invasive and non-invasive), type (wearable and non-wearable), distribution channel (institutional sales, hospitals, clinics, retail sales, hospital pharmacies, retail pharmacies, online pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Glucometer Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Glucometer Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Glucometer Market by Product
    • 3.3.1: Continuous Glucose Monitoring Devices
    • 3.3.2: Self-Monitoring Blood Glucose Systems
  • 3.4: Global Glucometer Market by Technique
    • 3.4.1: Invasive
    • 3.4.2: Non-Invasive
  • 3.5: Global Glucometer Market by Type
    • 3.5.1: Wearable
    • 3.5.2: Non-Wearable
  • 3.6: Global Glucometer Market by Distribution Channel
    • 3.6.1: Institutional Sales
    • 3.6.2: Hospitals
    • 3.6.3: Clinics
    • 3.6.4: Retail Sales
    • 3.6.5: Hospital Pharmacies
    • 3.6.6: Retail Pharmacies
    • 3.6.7: Online Pharmacies
    • 3.6.8: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Glucometer Market by Region
  • 4.2: North American Glucometer Market
    • 4.2.2: North American Glucometer Market by Technique: Invasive and Non-Invasive
    • 4.2.3: North American Glucometer Market by Type: Wearable and Non-Wearable
    • 4.2.4: North American Glucometer Market by Distribution Channel: Institutional Sales, Hospitals, Clinics, Retail Sales, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others
  • 4.3: European Glucometer Market
    • 4.3.1: European Glucometer Market by Product: Continuous Glucose Monitoring Devices and Self-Monitoring Blood Glucose Systems
    • 4.3.2: European Glucometer Market by Technique: Invasive and Non-Invasive
    • 4.3.3: European Glucometer Market by Type: Wearable and Non-Wearable
    • 4.3.4: European Glucometer Market by Distribution Channel: Institutional Sales, Hospitals, Clinics, Retail Sales, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others
  • 4.4: APAC Glucometer Market
    • 4.4.1: APAC Glucometer Market by Product: Continuous Glucose Monitoring Devices and Self-Monitoring Blood Glucose Systems
    • 4.4.2: APAC Glucometer Market by Technique: Invasive and Non-Invasive
    • 4.4.3: APAC Glucometer Market by Type: Wearable and Non-Wearable
    • 4.4.4: APAC Glucometer Market by Distribution Channel: Institutional Sales, Hospitals, Clinics, Retail Sales, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others
  • 4.5: ROW Glucometer Market
    • 4.5.1: ROW Glucometer Market by Product: Continuous Glucose Monitoring Devices and Self-Monitoring Blood Glucose Systems
    • 4.5.2: ROW Glucometer Market by Technique: Invasive and Non-Invasive
    • 4.5.3: ROW Glucometer Market by Type: Wearable and Non-Wearable
    • 4.5.4: ROW Glucometer Market by Distribution Channel: Institutional Sales, Hospitals, Clinics, Retail Sales, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Glucometer Market by Product
    • 6.1.2: Growth Opportunities for the Global Glucometer Market by Technique
    • 6.1.3: Growth Opportunities for the Global Glucometer Market by Type
    • 6.1.4: Growth Opportunities for the Global Glucometer Market by Distribution Channel
    • 6.1.5: Growth Opportunities for the Global Glucometer Market by Region
  • 6.2: Emerging Trends in the Global Glucometer Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Glucometer Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Glucometer Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: Promega Corporation
  • 7.3: Agilent Technologies
  • 7.4: Bio-Rad Laboratories
  • 7.5: QIAGEN
  • 7.6: Merck
  • 7.7: B.D.
  • 7.8: Sanofi
  • 7.9: Ascensia Diabetes Care Holdings
  • 7.10: Abbott